S. Aliberti (Milan, Italy), A. Shah (London, United Kingdom), A. Gramegna (Milano (MI), Italy), G. Suarez-Cuartin (Barcelona, Spain)
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
K. Nakamoto (Tokyo, Japan), Y. Sasaki (Tokyo, Japan), T. Shirai (Tokyo, Japan), K. Fujiwara (Tokyo, Japan), K. Furuuchi (Tokyo, Japan), T. Osawa (Tokyo, Japan), M. Shimoda (Tokyo, Japan), K. Yamana (Tokyo, Japan), K. Morimoto (Tokyo, Japan), R. Yano (Tokyo, Japan), M. Miyamoto (Tokyo, Japan), H. Kokuto (Tokyo, Japan), Y. Tanaka (Tokyo, Japan), M. Okumura (Tokyo, Japan), T. Uchiyama (Tokyo, Japan), K. Yoshimori (Tokyo, Japan), K. Ohta (Tokyo, Japan)
|  |
Frequency of side effects in antibiotic treatment for pneumonia
N. Hamao (Kyoto, Japan), I. Ito (Kyoto, Japan), S. Konishi (Kyoto, Japan), N. Tanabe (Kyoto, Japan), I. Oi (Kyoto, Japan), T. Hirai (Kyoto, Japan)
|  |
Corticosteroid therapy combined with antibiotics for severe Streptococcus pneumoniae pneumonia in ventilated piglets
M. Yang (Barcelona, Spain), G. Li Bassi (Barcelona, Spain), A. Motos (Barcelona, Spain), H. Yang (Barcelona, Spain), J. Bobi (Barcelona, Spain), A. Meli (Milan, Italy), D. Battaglini (Genoa, Italy), R. Cabrera (Barcelona, Spain), G. Tanzella (Genoa, Italy), C. Vargas (Barcelona, Spain), L. Fernandez-Barat (Barcelona, Spain), M. Rigol (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
Utility of BAL Galactomannan testing: A prospective analytical study
S. Sharma (Kolkata, India), S. Chakraboty (Kolkata, India), M. Ghosh (Kolkata, India), R. Dhar (Kolkata, India)
| |
Diagnostic yield and safety of flexible bronchoscopy for the diagnosis of pulmonary infections in patients with and without haematological malignancies
T. Mueller (Aachen, Germany), K. Von Schwanewede (Aachen, Germany), M. Dreher (Aachen, Germany)
| |
Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database.
T. Maitre (Paris, France), J. Cottenet (Dijon, France), C. Godet (Paris, France), P. Bonniaud (Dijon, France), C. Quantin (Dijon, France), J. Cadranel (Paris, France)
| |
Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
I. Falynskova (Moscow, Russian Federation), I. Leneva (Moscow, Russian Federation), A. Egorov (Moscow, Russian Federation), A. Poddubikov (Moscow, Russian Federation), R. Grabherr (Vienna, Austria), M. Klausberger (Vienna, Austria)
| |
Penicillin-resistant pneumococcal disease is not related to worse clinical outcomes in immunocompromised patients
D. Cavalet Blanco (Porto Alegre, Brazil), C. Jara Hernandes (Porto Alegre, Brazil), L. Zani Da Silva (Porto Alegre, Brazil), L. Ferreira Corrêa (Porto Alegre, Brazil), M. Tadday Rodrigues (Porto Alegre, Brazil), C. Rocha Dullius (Porto Alegre, Brazil)
| |
Hydatid disease of the lungs: an experience from a developing country
A. Butt (Karachi, Pakistan), J. Khan (Karachi, Pakistan)
| |
Mortality among patients admitted for viral lower respiratory tract infections – a seasonal cohort study
T. Moreira Marques (LISBON, Portugal), I. Moreira (LISBON, Portugal), A. Almeida (LISBON, Portugal), T. Ferreira (LISBON, Portugal), C. Pires (LISBON, Portugal), R. Corte Real (LISBON, Portugal)
| |
Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic
B. Seeliger (Hannover, Germany), K. Stahl (Hannover, Germany), M. Busch (Hannover, Germany), O. Wiesner (Hannover, Germany), T. Welte (Hannover, Germany), M. Hoeper (Hannover, Germany), M. Eder (Hannover, Germany), A. Heim (Hannover, Germany), S. David (Hannover, Germany)
| |
Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model
H. Yang (Barcelona, Spain), A. Motos (Barcelona, Spain), G. Li Bassi (Barcelona, Spain), E. Aguilera Xiol (Barcelona, Spain), F. Pagliara (Genoa, Italy), T. Senussi (Genoa, Italy), F. Idone (Roma, Italy), J. Bobi (Barcelona, Spain), R. Cabrera (Barcelona, Spain), L. Fernandez-Barat (Barcelona, Spain), M. Yang (Barcelona, Spain), D. Nicolau (Hartford, United States of America), P. Pelosi (Genoa, Italy), M. Antonelli (Roma, Italy), A. Torres (Barcelona, Spain)
| |
Clinical patterns of Pneumocystis Jirovecii in HIV and non-HIV patients
V. PARRA LEON (Madrid, Spain), W. Girón Matute (Madrid, Spain), C. Castro Riera (Madrid, Spain), Z. Ji (Madrid, Spain), J. Terán Tinedo (Madrid, Spain), L. Puente Maestu (Madrid, Spain)
| |
Home Quarantine experience
S. Smith (Sydney, Australia), G. Waterer (Perth, Australia), A. Cheng (Melbourne, Australia), P. Middleton (Sydney, Australia), P. Thompson (Perth, Australia)
| |
CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline.
D. Chen (Fuzhou, China), H. Li (Fuzhou, China), L. Xiao (Fuzhou, China), X. Li (Fuzhou, China), X. Hu (Fuzhou, China), H. He (Fuzhou, China), Y. Chen (Fuzhou, China)
| |
Characterization of influenza A, B and RSV infections in a Pulmonology ward during the 17/18 flu-season
J. Nunes Caldeira Marinho Matos (Coimbra, Portugal), S. Rodrigues Sousa (Coimbra, Portugal), M. Braz (Coimbra, Portugal), Y. Martins (Coimbra, Portugal), F. Barata (Coimbra, Portugal)
| |
Putting in Harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for Multidrug-Resistant Tuberculosis
G. Gualano (Rome, Italy), P. Mencarini (Rome, Italy), M. Musso (Rome, Italy), S. Mosti (Rome, Italy), S. Murachelli (Rome, Italy), A. Cannas (Rome, Italy), A. Di Caro (Rome, Italy), D. Goletti (Rome, Italy), E. Girardi (Rome, Italy), F. Palmieri (Rome, Italy)
| |
Prediction of dysphagia by thoracic muscle mass estimated by chest computed tomography in elderly pneumonia patients
J. Song (Seoul, Republic of Korea), K. Jin (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea), E. Heo (Seoul, Republic of Korea)
| |
Dynamic research of serum cryptococcal capsular polysaccharide antigen test and chest CT of pulmonary cryptococcosis without HIV
Y. Li (wenzhou, China), P. Lin (wenzhou, China), J. Ye (wenzhou, China), C. Chen (wenzhou, China)
| |
Evaluation of therapy for nursing and health care-associated pneumonia(NHCAP) patients based on Japanese new guidelines.
R. Hamanaka (Oita, Japan), U. Kenji (Oita, Japan), E. Mizukami (Oita, Japan), K. Komiya (Oita, Japan), Y. Usagawa (Oita, Japan), M. Yamasue (Oita, Japan), H. Yoshikawa (Oita, Japan), S. Nureki (Oita, Japan), M. Ando (Oita, Japan), K. Hiramatsu (Oita, Japan), J. Kadota (Oita, Japan)
| |